Mid-Day Market Update: Qihoo 360 Surges On Upbeat Results; Tyson Shares Decline
Midway through trading Monday, the Dow traded up 0.18 percent to 15,036.92 while the NASDAQ surged 0.59 percent to 3,679.49. The S&P also rose, gaining 0.26 percent to 1,667.80.
Under terms of the deal, Amgen will buy Onyx for $125 per share in cash. Amgen projects the deal to complete at the beginning of the fourth quarter.
Equities Trading UP
Qihoo 360 Technology Co (NYSE: QIHU) shot up 8.23 percent to $79.15 after the company reported upbeat Q2 results.
Amgen (NASDAQ: AMGN) was also up, gaining 9.16 percent to $115.27 after the company announced its plans to buy Onyx Pharmaceuticals (NASDAQ: ONXX) for $125 per share. Analysts at Piper Jaffray upgraded Amgen from Neutral to Overweight.
Equities Trading DOWN
Shares of Tyson Foods (NYSE: TSN) were down 6.08 percent to $29.57 after analysts at Bank of America downgraded the stock from Buy to Neutral.
CNH Global NV (NYSE: CNH) shares tumbled 2.15 percent to $48.72 after the company announced the resignation of its Chief Financial Officer Pablo Di Si.
Microsoft (NASDAQ: MSFT) was down, falling 1.15 percent to $34.35. On Friday, the company reported that its CEO Ballmer will step down within the next 12 months. Nomura reiterated its Buy rating on the stock.
In commodity news, oil traded down 0.70 percent to $105.67, while gold traded down 0.27 percent to $1,392.00.
Silver traded up 1.89 percent Monday to $24.23, while copper fell 0.92 percent to $3.33.
European shares were mostly lower today. The Spanish Ibex Index dropped 0.42 percent, while Italy's FTSE MIB Index tumbled 2.10%. Meanwhile, the German DAX gained 0.22 percent and the French CAC 40 dropped 0.06 percent.
US durable-goods orders declined 7.3% in July, versus economists' expectations for a 4.9% fall. However, core durable-goods orders dropped 0.60% in the month.
The Dallas Fed general business activity index rose to 5.00 in August, versus a prior reading of 4.40. However, economists were expecting a reading of 4.00.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.